Hence, we hypothesized that stem cell-derived CCL2 signalling to recruit Ly6C+ macrophages provides a critical microenvironment for determining the immunosuppressive capacity of MSCs and has a profound effect on the treatment of liver fibrosis. This evidence concerns the gene CCL2 and Hepatic fibrosis.